Primary myeloma cells growing in SCID-hu mice: A model for studying the biology and treatment of myeloma and its manifestations

Blood

Volumn 92, Issue 8, 1998, Pages 2908-2913

  Yaccoby, Shmuel ^a   Barlogie, Bart ^a   Epstein, Joshua ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; MYELOMA; PRIORITY JOURNAL; SCID MOUSE;

EID: 0032532608     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.8.2908.420a32_2908_2913     Document Type: Article

References (31)

1. Pilarski LM, Belch AR: Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma. Blood 83:724, 1994
2. Pilarski LM, Jensen GS: Monoclonal circulating B cells in multiple myeloma. A continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules [Review]. Hematol Oncol Clin North Am 6:297, 1992
3. Bergui L, Schena M, Gaidano G, Riva M, Caligaris-Cappio F: Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma. J Exp Med 170:613, 1989
4. Chen BJ, Epstein J: Circulating clonal lymphocytes in myeloma Constitute a minor subpopulation of Bb cells [see comments]. Blood 87:1972, 1996
5. Kay NE, Leong T, Kyle RA, Greipp P, Billadeau D, Van Ness B, Bone N, Oken MM: Circulating blood B cells in multiple myeloma: Analysis and relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the Eastern Cooperative Oncology Group phase III E9486 clinical trial. Blood 90:340, 1997
6. Billadeau D, Ahmann G, Greipp P, Van Ness B: The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J Exp Med 178:1023, 1993
7. Corradini P, Boccadoro M, Voena C, Pileri A: Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C mu sequence in immunuglobulin (IgG)- and IgA-secreting multiple myelomas. J Exp Med 178:1091, 1993
8. Rettig MB, Ma HJ, Vescio RA, Pold M, Schiller G, Belson D, Savage A, Nishikubo C, Wu C, Fraser J, Said JW, Berenson JR: Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients [see comments]. Science 276:1851, 1997
9. Said JW, Rettig MR, Heppner K, Vescio RA, Schiller G, Ma HJ, Belson D, Savage A, Shintaku IP, Koeffler HP, Asou H, Pinkus G, Pinkus J, Schrage M, Green E, Berenson JR: Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. Blood 90:4278, 1997
10. Cattan AR, Douglas E: The C.B. 17 scid mouse strain as a model for human disseminated leukaemia and myeloma in vivo. Leuk Res 18:513, 1994
11. Tong AW, Huang YW, Zhang BQ, Netto G, Vitetta ES, Stone MJ: Heterotransplantation of human multiple myeloma cell lines in severe combined immunodeficiency (SCID) mice. Anticancer Res 13:593, 1993
12. Bellamy WT, Odeleye A, Finley P, Huizenga B, Dalton WS, Weinstein RS, Hersh EM, Grogan TM: An in vivo model of human multidrug-resistant multiple myeloma in SCID mice. Am J Pathol 142:691, 1993
13. Huang YW, Richardson JA, Tong AW, Zhang BQ, Stone MJ, Vitetta ES: Disseminated growth of a human multiple myeloma cell line in mice with severe combined immunodeficiency disease. Cancer Res 53:1392, 1993
14. Suzuki H, Yasukawa K, Saito T, Goitsuka R, Hasegawa A, Ohsugi Y, Taga T, Kishimoto T: Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo. Eur J Immunol 22:1989, 1992
15. Huang YW, Richardson JA, Vitetta ES: Anti-cd54 (icam-1) has antitumor activity in scid mice with human myeloma cells. Cancer Res 55:610, 1995
16. Bellamy WT, Mendibles P, Bontje P, Thompson F, Richter L, Weinstein RS, Grogan TM: Development of an orthotopic SCID mouse-human tumor xenograft model displaying the multidrug-resistant phenotype. Cancer Chemother Pharmacol 37:305, 1996
17. Feo-Zuppardi FJ, Taylor CW, Iwato K, Lopez MH, Grogan TM, Odeleye A, Hersh EM, Salmon SE: Long-term engraftment of fresh human myeloma cells in SCID mice. Blood 80:2843, 1992
18. Kaneshima H, Baum C, Chen B, Namikawa R, Outzen H, Rabin L, Tsukamoto A, McCune JM: Today's SCID-hu mouse. Nature 348:561, 1990
19. Namikawa R, Weilbaecher KN, Kaneshima H, Yee EJ, McCune JM: Long-term human hematopoiesis in the SCID-hu mouse. J Exp Med 172:1055, 1990
20. DiGiusto D, Chen S, Combs J, Webb S, Namikawa R, Tsukamoto A, Chen BP, Galy AH: Human fetal bone marrow early progenitors for T, B, and myeloid cells are found exclusively in the population expressing high levels of CD34. Blood 84:421, 1994
21. Hata H, Xiao H, Petrucci MT, Woodliff J, Chang R, Epstein J: Interleukin-6 gene expression in multiple myeloma: A characteristic of immature tumor cells. Blood 81:3357, 1993
22. Billadeau D, Blackstadt M, Greipp P, Kyle RA, Oken MM, Kay N, Van Ness B: Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: A technique for sequential quantitation of residual disease. Blood 78:3021, 1991
23. Namikawa R, Ueda R, Kyoizumi S: Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice. Blood 82:2526, 1993
24. Alsina M, Boyce B, Devlin RD, Anderson JL, Craig F, Mundy GR, Roodman GD: Development of an in vivo model of human multiple myeloma bone disease. Blood 87:1495, 1996
25. Pringle JH, Primrose L, Kind CN, Talbot IC, Lauder I: In situ hybridization demonstration of poly-adenylated RNA sequences in formalin-fixed paraffin sections using a biotinylaced oligonucleotide poly d(T) probe. J Pathol 158:279, 1989
26. Brown R, Luo XF, Gibson J, Morley A, Sykes P, Brisco M, Joshua D: Idiotypic oligonucleotide probes to detect myeloma cells by mRNA in situ hybridization. Br J Haematol 90:113, 1995
27. Miyashita EM, Yang B, Lam KM, Crawford DH, Thorley-Lawson DA: A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 80:593, 1995
28. Urashima M, Chen BP, Chen S, Pinkus GS, Bronson RT, Dedera DA, Hoshi Y, Teoh G, Ogata A, Treon SP, Chauhan D, Anderson KC: The development of a model for the homing of multiple myeloma cells to human bone marrow. Blood 90:754, 1997
29. Vacca A, Ribatti D, Roncali L, Dammacco F: Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies [Review]. Leuk Lymphoma 20:27, 1995
30. Vacca A, Di LM, Ribatti D, Di SR, Gadaleta-Caldarola G, Iodice G, Caloro D, Dammacco F: Bone marrow of patients with active multiple myeloma: Angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1, and CD44. Am J Hematol 50:9, 1995
31. Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F, Dammacco F: Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 87:503, 1994